Insulin Kinetics in Type-1 Diabetes: Continuous and Bolus Delivery of Rapid Acting Insulin
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We investigated insulin lispro kinetics with bolus and continuous subcutaneous insulin infusion (CSII) modes of insulin delivery. Seven subjects with type-1 diabetes treated by CSII with insulin lispro have been studied during prandial and postprandial conditions over 12 hours. Eleven alternative models of insulin kinetics have been proposed implementing a number of putative characteristics. We assessed 1) the effect of insulin delivery mode, i.e., bolus or basal, on the insulin absorption rate, the effects of 2) insulin association state and 3) insulin dose on the rate of insulin absorption, 4) the remote insulin effect on its volume of distribution, 5) the effect of insulin dose on insulin disappearance, 6) the presence of insulin degradation at the injection site, and finally 7) the existence of two pathways, fast and slow, of insulin absorption. An iterative two-stage parameter estimation technique was used. Models were validated through assessing physiological feasibility of parameter estimates, posterior identifiability, and distribution of residuals. Based on the principle of parsimony, best model to fit our data combined the slow and fast absorption channels and included local insulin degradation. The model estimated that 67(53-82)% [mean (interquartile range)] of delivered insulin passed through the slow absorption channel [absorption rate 0.011(0.004-0.029) min(-1)] with the remaining 33% passed through the fast channel [absorption rate 0.021(0.011-0.040) min(-1)]. Local degradation rate was described as a saturable process with Michaelis-Menten characteristics [VMAX = 1.93(0.62 - 6.03) mU min(-1), KM = 62.6(62.6 - 62.6) mU]. Models representing the dependence of insulin absorption rate on insulin disappearance and the remote insulin effect on its volume of distribution could not be validated suggesting that these effects are not present or cannot be detected during physiological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
Self-citationBinder, C., Lauritzen, T., Faber, O., & Pramming, S. (1984) · Diabetes Care · doi:10.2337/diacare.7.2.188 · Cited by 341
Models of subcutaneous insulin kinetics. A critical review
Nucci, G., & Cobelli, C. (2000) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(00)00071-7 · Cited by 189
Kobayashi, T., Sawano, S., Itoh, T., Kosaka, K., Hirayama, H., & Kasuya, Y. (1983) · Diabetes · doi:10.2337/diab.32.4.331 · Cited by 86
Cited by
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
“The model, coupled to a subcutaneous insulin kinetic model [142], consists of 11 dif-”
GIM, Simulation Software of Meal Glucose–Insulin Model
Dalla Man, C., Raimondo, D. M., Rizza, R. A., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100303 · Cited by 253
Jacobs, P. G., Resalat, N., El Youssef, J., Reddy, R., Branigan, D., Preiser, N., Condon, J., & Castle, J. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815609371 · Cited by 105
Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning
Vehí, J., Contreras, I., Oviedo, S., Biagi, L., & Bertachi, A. (2020) · Health Informatics Journal · doi:10.1177/1460458219850682 · Cited by 76
“…•• The insulin that remains active within the body can be represented using a two-compartment model that estimates the insulin on board (IOB), 22 which is an estimation of the residual insulin accumulated in the subcutaneous tissue where t is the time instant, the compartments C 1 and C 2…”
MethodHaidar, A., Wilinska, M. E., Graveston, J. A., & Hovorka, R. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2272736 · Cited by 69
Self-citationGlucose Clamp Algorithms and Insulin Time-Action Profiles
Bequette, B. W. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300503 · Cited by 43
Youssef, J. E., Castle, J. R., Branigan, D. L., Massoud, R. G., Breen, M. E., Jacobs, P. G., Bequette, B. W., & Ward, W. K. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500602 · Cited by 42
Mathematical modeling and analysis of insulin clearance in vivo
Koschorreck, M., & Gilles, E. D. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-43 · Cited by 35
Modeling impulsive insulin delivery in insulin pump with time delays
Song, X., Huang, M., & Li, J. (2014) · SIAM Journal on Applied Mathematics · doi:10.1137/130933137 · Cited by 35
Design of a dual-hormone model predictive control for artificial pancreas with exercise model
Resalat, N., El Youssef, J., Reddy, R., & Jacobs, P. G. (2016) · 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7591182 · Cited by 34
Resalat, N., Youssef, J. E., Reddy, R., & Jacobs, P. G. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.2270 · Cited by 15
Faggionato, E., Schiavon, M., & Dalla Man, C. (2021) · Metabolites · doi:10.3390/metabo11040235 · Cited by 15
Metadata
- Authors
- Wilinska, M. E., Chassin, L. J., Schaller, H. C., Schaupp, L., Pieber, T. R., & Hovorka, R.
- Venue
- IEEE Transactions on Biomedical Engineering
- Published
- 2005-01
- Volume
- 52
- Issue
- 1
- Pages
- 3-12
- ISSN
- 0018-9294 (ISSN-L)
- OpenAlex
- W2163532367
- Cited by
- 237
- References
- 4
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.